Emergent BioSolutions (EBS) Gross Margin Growth (1y) (2012 - 2026)
Emergent BioSolutions (EBS) Gross Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 604.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 604.00 |
| Mar 31, 2026 | -630.00 |
| Dec 31, 2025 | 351.00 |
| Sep 30, 2025 | 456.00 |
| Mar 31, 2025 | 831.00 |
| Dec 31, 2024 | 631.00 |
| Sep 30, 2024 | 2,363.00 |
| Mar 31, 2024 | 4,493.00 |
| Dec 31, 2023 | -1,625.00 |
| Sep 30, 2023 | -400.00 |
| Jun 30, 2023 | -2,351.00 |
| Mar 31, 2023 | -6,672.00 |
| Dec 31, 2022 | -5,042.00 |
| Sep 30, 2022 | -4,851.00 |
| Jun 30, 2022 | -1,133.00 |
| Mar 31, 2022 | -1,239.00 |
| Dec 31, 2021 | 8,018.00 |
| Sep 30, 2021 | -538.00 |
| Jun 30, 2021 | 1,132.00 |
| Mar 31, 2021 | 2,600.00 |